Regeneron Pharmaceuticals (REGN) Current Deferred Tax Assets (2012 - 2015)

Regeneron Pharmaceuticals (REGN) posted quarterly Current Deferred Tax Assets of $60.5 million for Q3 2015, up 23.5% year-over-year from $49.0 million in Q3 2014, and down 13.05% quarter-over-quarter from $69.6 million in Q2 2015.

Regeneron Pharmaceuticals (REGN) Current Deferred Tax Assets (2012 - 2015) Analysis & Trends

Regeneron Pharmaceuticals' Current Deferred Tax Assets history runs 4 years deep, the most recent figure standing at $60.5 million for Q3 2015.

  • In Q3 2015, Current Deferred Tax Assets rose 23.5% year-over-year to $60.5 million; the TTM figure through Sep 2015 stood at $60.5 million (up 23.5% YoY), while the FY2014 annual figure was $46.2 million, up 3.36% from the prior year.
  • Current Deferred Tax Assets for Q3 2015 stood at $60.5 million, down from $69.6 million in the prior quarter.
  • The five-year high for Current Deferred Tax Assets was $148.1 million in Q4 2012, with the low at $36.6 million in Q1 2014.
  • The 4-year median for Current Deferred Tax Assets is $47.6 million (2014), against an average of $61.0 million.
  • The sharpest annual moves came in 2013 and 2015: Current Deferred Tax Assets plunged 69.84% in 2013, then soared 86.65% in 2015.
  • Regeneron Pharmaceuticals' Current Deferred Tax Assets stood at $148.1 million in 2012, then plunged by 69.84% to $44.7 million in 2013, then rose by 3.36% to $46.2 million in 2014, then surged by 31.06% to $60.5 million in 2015.
  • Business Quant data shows REGN's Current Deferred Tax Assets at $60.5 million in Q3 2015, $69.6 million in Q2 2015, and $62.1 million in Q1 2015.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn

Historic Data

Download Data
DateValue
Sep 30, 2015 60.52 Mn
Sep 30, 2015 60.52 Mn
Jun 30, 2015 69.60 Mn
Jun 30, 2015 69.60 Mn
Mar 31, 2015 62.13 Mn
Mar 31, 2015 62.13 Mn
Dec 31, 2014 46.18 Mn
Dec 31, 2014 46.18 Mn
Sep 30, 2014 49.01 Mn
Sep 30, 2014 49.01 Mn
Jun 30, 2014 37.29 Mn
Jun 30, 2014 37.29 Mn
Mar 31, 2014 36.62 Mn
Mar 31, 2014 36.62 Mn
Dec 31, 2013 44.68 Mn
Dec 31, 2013 44.68 Mn
Sep 30, 2013 39.17 Mn
Sep 30, 2013 39.17 Mn
Jun 30, 2013 38.93 Mn
Jun 30, 2013 38.93 Mn